Clear Street’s Japer Therapeutics Warrants JSPRW Stock Holding History

Clear Street’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$4	–	1138
2025 Q4	$4	Sell	100 -20	-17%	-$2	﹤0.01%	923
2025 Q3	$10	Buy	+120	New	+$10	﹤0.01%	833

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clear Street's JSPRW Position: Q1 2026 in Review

Clear Street sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2026, closing a stake of 100 shares — an estimated $4 sold.

Clear Street first reported a position in JSPRW in Q3 2025 and held it in 2 quarters. The position peaked at $10 in Q3 2025. 7 funds tracked by Wall St. Rank hold JSPRW as of Q1 2026.

Clear Street reported no remaining Japer Therapeutics Warrants position as of Q1 2026 after selling out during the quarter.
Clear Street sold 100 Japer Therapeutics Warrants shares in Q1 2026, an estimated $4.
Clear Street first reported a position in Japer Therapeutics Warrants in Q3 2025 and held it in 2 quarters.
Clear Street's Japer Therapeutics Warrants position peaked at $10 in Q3 2025.
7 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.